Ph II Randomized Trial of Radiotherapy w Pembrolizumab vs Chemotherapy in Patient w HNSCC
Full Title:
Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab Keytruda Versus Concurrent Chemotherapy in Patients with AdvancedIntermediateRisk p16 Head and Neck Squamous Cell Carcinoma KEYCHAIN Trial
Status:
OPEN TO ACCRUAL
Protocol Number:
2001268464
Principal Investigator:
Phase:
II
Prevention or Control:
Age Group:
Scope:
Disease Site(s):
Larynx
Lip, Oral Cavity and Pharynx
National Institutes of Health - ClinicalTrials.gov NCT Number: NCT03383094